Pallares-Mendez Rigoberto, Brassetti Aldo, Bove Alfredo Maria, Simone Giuseppe
Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00128 Rome, Italy.
J Clin Med. 2024 Aug 21;13(16):4927. doi: 10.3390/jcm13164927.
New insights in the urinary microbiome have led to a better understanding being built of the shifts in bacterial representations from health to disease; these hold promise as markers for diagnosis and therapeutic responses. Although several efforts have been made to identify a "core urinary microbiome", different fingerprints have been identified in men and women that shift with age. The main bacterial groups overall include , , , and . Although patients with bladder cancer have a microbiome that is similar to that of healthy individuals, differences have been observed at the species level with and , and at the genus level with . Different bacterial representations may influence extracellular matrix composition, affecting tumor metastatic spreading and tumorigenic metalloproteinase expression. Furthermore, gene expression affecting targets of immune therapy, such as PD-L1, has been associated with changes in bacterial representations and therapeutic response to BCG. This comprehensive review aims to examine the influence of the urinary microbiome in bladder cancer.
对泌尿微生物群的新见解使人们对从健康到疾病的细菌表现变化有了更好的理解;这些有望作为诊断和治疗反应的标志物。尽管已经做出了多项努力来识别“核心泌尿微生物群”,但在男性和女性中已识别出随年龄变化的不同指纹图谱。总体上主要的细菌类别包括 、 、 和 。虽然膀胱癌患者的微生物群与健康个体相似,但在物种水平上已观察到 和 存在差异,在属水平上 也存在差异。不同的细菌表现可能会影响细胞外基质组成,影响肿瘤转移扩散和致瘤性金属蛋白酶表达。此外,影响免疫治疗靶点(如PD-L1)的基因表达与细菌表现变化及卡介苗治疗反应有关。这篇综述旨在探讨泌尿微生物群在膀胱癌中的影响。